Fingerprint
Dive into the research topics of 'Experience with gemtuzumab ozogamycin ("mylotarg") and all-trans retinoic acid in untreated acute promyelocytic leukemia'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Experience with gemtuzumab ozogamycin ("mylotarg") and all-trans retinoic acid in untreated acute promyelocytic leukemia
Elihu H. Estey*, Francis J. Giles, Miloslav Beran, Susan O'Brien, Sherry A. Pierce, Stefan H. Faderl, Jorge E. Cortes, Hagop M. Kantarjian
*Corresponding author for this work
Research output: Contribution to journal › Article › peer-review
166
Scopus
citations